Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • Pretreatment of caffeine leads...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

Pretreatment of caffeine leads to partial neuroprotection in MPTP model of Parkinson's disease

Bibliographic Details
Published in:Neural Regeneration Research
Main Authors: Puneet Bagga, Anant B Patel
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2016;volume=11;issue=11;spage=1750;epage=1751;aulast=Bagga
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.nrronline.org/article.asp?issn=1673-5374;year=2016;volume=11;issue=11;spage=1750;epage=1751;aulast=Bagga

Similar Items

  • Amiloride is neuroprotective in an MPTP model of Parkinson's disease
    by: Robert L. Arias, et al.
    Published: (2008-09-01)
  • Neuroprotective effects of Neurotrophin-3 in MPTP-induced zebrafish Parkinson’s disease model
    by: Noor Azzizah Omar, et al.
    Published: (2023-11-01)
  • Neuroprotective Effect of Ghrelin on Substantia Nigra in Parkinson Disease Model Induced -MPTP
    by: Neda Nikoklam Nazif
    Published: (2019-10-01)
  • TFP5/TP5 peptide provides neuroprotection in the MPTP model of Parkinson′s disease
    by: B K Binukumar, et al.
    Published: (2016-01-01)
  • Preparation and Neuroprotective Activity of Glucuronomannan Oligosaccharides in an MPTP-Induced Parkinson’s Model
    by: Yingjuan Liu, et al.
    Published: (2020-08-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs